Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Patent coverage granted for LXR antidiarrheal agent

Feb. 10, 1997

Isis updates activities related to ISIS-2302

Feb. 7, 1997

Lilly/Novo Nordisk discover candidate for IBS

Feb. 6, 1997

5-HT4 antagonists disclosed by Taisho

Feb. 6, 1997

Hepatoprotective activity of Chinese medicine tested in animal models

Feb. 4, 1997

Structural Bioinformatics and CyberChemics collaborate on viral protease inhibitors

Feb. 3, 1997

Sankyo prepares prostaglandin derivatives for ulcers

Feb. 3, 1997

Iceland moss component displays anti-H. pylori activity in vitro

Jan. 31, 1997

Yuhan hepatoprotectant in phase II

Jan. 29, 1997

Antiulcer agents from Otsuka

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...